<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1533">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03086915</url>
  </required_header>
  <id_info>
    <org_study_id>KDAR FN Brno 3/2017</org_study_id>
    <nct_id>NCT03086915</nct_id>
  </id_info>
  <brief_title>Myorelaxation Practice in Paediatric Anesthesia</brief_title>
  <acronym>PAMPE</acronym>
  <official_title>Myorelaxation Practice in Paediatric Anesthesia: Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brno University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Faculty of medicine, Masaryk University Brno</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brno University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In retrospective data search the investigators will identified the percentage of patients
      with muscle relaxants administered during perioperative period. The block reversal, typ of
      drug, percentage of cases with and without reversal will be identified.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The actual percentage of surgeries with the muscle relaxants administered during
      perioperative period in paediatric patients remain unclear because many surgeries are being
      performed without muscle relaxation. In this retrospective study, the anesthesiology
      perioperative data from January 2016 till December 2016 in the tertiary center od Pediatric
      anesthesia will be searched for the percentage of surgeries with muscle relaxants
      administered. Type of surgery, age, weight, duration u surgery, muscle relaxants drug and
      percentage of block reversal will be identified.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2017</start_date>
  <completion_date type="Anticipated">August 1, 2017</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of neuromuscular block reversal</measure>
    <time_frame>1 year</time_frame>
    <description>The actual percentage of paediatric patients with perioperative neuromuscular blockade with active pharmacology block reversal at the end of surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of surgeries without muscle relaxant administration</measure>
    <time_frame>1 year</time_frame>
    <description>Paediatric surgeries without neuromuscular blocking agent administration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of neuromuscular blocking agent in paediatric anesthesiology practice</measure>
    <time_frame>1 year</time_frame>
    <description>Actual type of neuromuscular blocking agent used in paediatric anesthesiology practice in predefined period.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>Patients with neuromuscular block</arm_group_label>
    <description>Neuromuscular blocking agent administrated during surgery to the paediatric patient</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neuromuscular Blocking Agent</intervention_name>
    <description>Administration of neuromuscular blockers during anesthesia</description>
    <arm_group_label>Patients with neuromuscular block</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Paediatric anesthesiology patients who underwent surgery with neuromuscular blocking agent
        administered during surgery in tertiary center paediatric anesthesiology department
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  paediatric patients

          -  the study period (1/2016-12/2016)

          -  neuromuscular blocking agent administration during surgery

        Exclusion Criteria:

          -  surgery without neuromuscular blockade
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>20 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Petr Štourač, Doc.MD.P.hD</last_name>
    <phone>532234404</phone>
    <phone_ext>00420</phone_ext>
    <email>Stourac.Petr@fnbrno.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jozef Klučka, MD</last_name>
    <phone>532234404</phone>
    <phone_ext>00420</phone_ext>
    <email>Klucka.Jozef@fnbrno.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brno University Hospital</name>
      <address>
        <city>Brno</city>
        <zip>62500</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petr Štourač, Doc.MD.Ph.D</last_name>
      <phone>532234404</phone>
      <phone_ext>00420</phone_ext>
      <email>Stourac.Petr@fnbrno.cz</email>
    </contact>
    <contact_backup>
      <last_name>Jozef Klučka, MD</last_name>
      <phone>532234404</phone>
      <phone_ext>00420</phone_ext>
      <email>Klucka.Jozef@fnbrno.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 16, 2017</lastchanged_date>
  <firstreceived_date>March 5, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brno University Hospital</investigator_affiliation>
    <investigator_full_name>Petr Štourač, MD</investigator_full_name>
    <investigator_title>doc. MD. Ph.D</investigator_title>
  </responsible_party>
  <keyword>neuromuscular blockade</keyword>
  <keyword>muscle relaxation</keyword>
  <keyword>muscle relaxant</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Neuromuscular Blocking Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
